New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
11:18 EDTNUAN, SRPT, IGT, YPF, SBGI, TLM, WMB, APC, MDTOptions with increasing implied volatility
Options with increasing implied volatility: NUAN SRPT IGT YPF SBGI TLM WMB APC MDT
News For NUAN;SRPT;IGT;YPF;SBGI;TLM;WMB;APC;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 12, 2014
19:26 EDTSRPTPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTSRPTCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
14:18 EDTSRPTNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTSRPTTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
10:54 EDTSRPTMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
08:48 EDTSBGISinclair Broadcast has positive catalysts, fears overdone, says RBC Capital
Subscribe for More Information
08:31 EDTWMBGoldman remains bullish on MLPs
Subscribe for More Information
07:04 EDTMDTMedtronic announces Omar Ishrak will remain CEO of new company
Subscribe for More Information
October 9, 2014
14:55 EDTSRPTHospital says deputy showing no signs of Ebola, AP reports
Subscribe for More Information
14:24 EDTSRPTCDC head compares Ebola to AIDS, Washington Post says
Subscribe for More Information
14:13 EDTSRPTFirst Ebola vaccine trial in West Africa started, NBC News reports
Subscribe for More Information
12:06 EDTSRPTLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
11:37 EDTAPCStocks with call strike movement; RIG APC
Transocean (RIG) January 34 call option implied volatility increased 5% to 38, Anadarko (APC) January 115 call option implied volatility increased 8% to 39 according to IVolatility.
06:12 EDTAPCAnadarko implied volatility of 37 at upper end of index mean range
October 8, 2014
18:31 EDTNUANOn The Fly: After Hours Movers
UP AFTER EARNINGS: Ruby Tuesday (RT), up 19.6%... Exar (EXAR), up 13.7% after reporting second quarter revenue guidance... Alcoa (AA), up 2.2%. ALSO HIGHER: Nuance (NUAN), up 2.5% following rumors that Carl Icahn will recommend that Apple (AAPL) buy the company... GrubHub (GRUB), up just under 1% after being initiated with a Buy at CRT Capital. DOWN AFTER EARNINGS: Kofax (KFX), down 20.1% after reporting first quarter revenue and fiscal 2015 revenue guidance below analyst estimates... ARC Group (ARCW), down 17%... E2open (EOPN), down 8.9%. ALSO LOWER: Gap (GPS), down 7.6% following September same store sales data and CEO transition... AMD (AMD), down 7% after announcing CEO transition.
16:26 EDTNUANOn The Fly: Closing Wrap
Subscribe for More Information
15:12 EDTNUANNuance October calls active amid speculation Icahn speculation
Subscribe for More Information
15:05 EDTNUANRumor: Nuance moves off lows amid Icahn speculation
Subscribe for More Information
13:54 EDTYPFMinister says Gazprom, YPF discussing $1B agreement, Bloomberg says
Subscribe for More Information
11:22 EDTSRPTChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use